Diaphorina citri psyllid: psy9785


Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60---
MAEEENSNEENSANDMNTKFGLKIRGRKGALKKKNVYNVKDHKFIPRFFKQPTFCSHCKDFIW
cccccccccccccccccccccccccccccHHHHccEEEccccEEEcccccccccccccccccc
***********************IRGRKGALKKKNVYNVKDHKFIPRFFKQPTFCSHCKDFIW
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
MAEEENSNEENSANDMNTKFGLKIRGRKGALKKKNVYNVKDHKFIPRFFKQPTFCSHCKDFIW

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
Protein kinase C, brain isozyme PKC is activated by diacylglycerol which in turn phosphorylates a range of cellular proteins. PKC also serves as the receptor for phorbol esters, a class of tumor promoters.confidentP05130
Protein kinase C alpha type Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Depending on the cell type, is involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation. In cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Depending on the cell type, exhibits anti-apoptotic function and protects cells from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, or mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)-dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B-ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF-kappa-B-induced genes, through IL1A-dependent induction of NF-kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity.confidentP20444
Protein kinase C alpha type Calcium-activated, phospholipid- and diacylglycerol (DAG)-dependent serine/threonine-protein kinase that is involved in positive and negative regulation of cell proliferation, apoptosis, differentiation, migration and adhesion, tumorigenesis, cardiac hypertrophy, angiogenesis, platelet function and inflammation, by directly phosphorylating targets such as RAF1, BCL2, CSPG4, TNNT2/CTNT, or activating signaling cascade involving MAPK1/3 (ERK1/2) and RAP1GAP. Involved in cell proliferation and cell growth arrest by positive and negative regulation of the cell cycle. Can promote cell growth by phosphorylating and activating RAF1, which mediates the activation of the MAPK/ERK signaling cascade, and/or by up-regulating CDKN1A, which facilitates active cyclin-dependent kinase (CDK) complex formation in glioma cells. In intestinal cells stimulated by the phorbol ester PMA, can trigger a cell cycle arrest program which is associated with the accumulation of the hyper-phosphorylated growth-suppressive form of RB1 and induction of the CDK inhibitors CDKN1A and CDKN1B. Exhibits anti-apoptotic function in glioma cells and protects them from apoptosis by suppressing the p53/TP53-mediated activation of IGFBP3, and in leukemia cells mediates anti-apoptotic action by phosphorylating BCL2. During macrophage differentiation induced by macrophage colony-stimulating factor (CSF1), is translocated to the nucleus and is associated with macrophage development. After wounding, translocates from focal contacts to lamellipodia and participates in the modulation of desmosomal adhesion. Plays a role in cell motility by phosphorylating CSPG4, which induces association of CSPG4 with extensive lamellipodia at the cell periphery and polarization of the cell accompanied by increases in cell motility. Is highly expressed in a number of cancer cells where it can act as a tumor promoter and is implicated in malignant phenotypes of several tumors such as gliomas and breast cancers. Negatively regulates myocardial contractility and positively regulates angiogenesis, platelet aggregation and thrombus formation in arteries. Mediates hypertrophic growth of neonatal cardiomyocytes, in part through a MAPK1/3 (ERK1/2)-dependent signaling pathway, and upon PMA treatment, is required to induce cardiomyocyte hypertrophy up to heart failure and death, by increasing protein synthesis, protein-DNA ratio and cell surface area. Regulates cardiomyocyte function by phosphorylating cardiac troponin T (TNNT2/CTNT), which induces significant reduction in actomyosin ATPase activity, myofilament calcium sensitivity and myocardial contractility. In angiogenesis, is required for full endothelial cell migration, adhesion to vitronectin (VTN), and vascular endothelial growth factor A (VEGFA)-dependent regulation of kinase activation and vascular tube formation. Involved in the stabilization of VEGFA mRNA at post-transcriptional level and mediates VEGFA-induced cell proliferation. In the regulation of calcium-induced platelet aggregation, mediates signals from the CD36/GP4 receptor for granule release, and activates the integrin heterodimer ITGA2B-ITGB3 through the RAP1GAP pathway for adhesion. During response to lipopolysaccharides (LPS), may regulate selective LPS-induced macrophage functions involved in host defense and inflammation. But in some inflammatory responses, may negatively regulate NF-kappa-B-induced genes, through IL1A-dependent induction of NF-kappa-B inhibitor alpha (NFKBIA/IKBA). Upon stimulation with 12-O-tetradecanoylphorbol-13-acetate (TPA), phosphorylates EIF4G1, which modulates EIF4G1 binding to MKNK1 and may be involved in the regulation of EIF4E phosphorylation. Phosphorylates KIT, leading to inhibition of KIT activity.confidentP17252

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0018107 [BP]peptidyl-threonine phosphorylationconfidentGO:0044267, GO:0006468, GO:0009987, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0018210, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0018193, GO:0008152, GO:0006793, GO:0044237
GO:0044763 [BP]single-organism cellular processconfidentGO:0009987, GO:0008150, GO:0044699
GO:0048523 [BP]negative regulation of cellular processconfidentGO:0008150, GO:0048519, GO:0065007, GO:0050789, GO:0050794
GO:0048522 [BP]positive regulation of cellular processconfidentGO:0048518, GO:0008150, GO:0065007, GO:0050789, GO:0050794
GO:0016020 [CC]membraneconfidentGO:0005575
GO:0050896 [BP]response to stimulusconfidentGO:0008150
GO:0004674 [MF]protein serine/threonine kinase activityconfidentGO:0016773, GO:0016772, GO:0016301, GO:0003824, GO:0016740, GO:0003674, GO:0004672
GO:0044444 [CC]cytoplasmic partconfidentGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044424
GO:0005634 [CC]nucleusconfidentGO:0043231, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0043229, GO:0044424, GO:0043227, GO:0043226
GO:0043005 [CC]neuron projectionconfidentGO:0005575, GO:0097458, GO:0042995, GO:0044464, GO:0005623
GO:0048583 [BP]regulation of response to stimulusconfidentGO:0008150, GO:0065007, GO:0050789
GO:0001750 [CC]photoreceptor outer segmentprobableGO:0072372, GO:0043231, GO:0044464, GO:0005623, GO:0031513, GO:0005575, GO:0043229, GO:0005929, GO:0044424, GO:0042995, GO:0043227, GO:0043226, GO:0005622
GO:0043025 [CC]neuronal cell bodyprobableGO:0005575, GO:0097458, GO:0044297, GO:0005623, GO:0044464
GO:0004698 [MF]calcium-dependent protein kinase C activityprobableGO:0003824, GO:0016773, GO:0016772, GO:0016301, GO:0009931, GO:0004674, GO:0016740, GO:0003674, GO:0004672, GO:0010857, GO:0004697
GO:0030425 [CC]dendriteprobableGO:0044464, GO:0005623, GO:0005575, GO:0097458, GO:0043005, GO:0042995
GO:0097060 [CC]synaptic membraneprobableGO:0005575, GO:0044456, GO:0016020, GO:0045202
GO:0010613 [BP]positive regulation of cardiac muscle hypertrophyprobableGO:0014742, GO:0010611, GO:0044057, GO:0051240, GO:0014743, GO:0065007, GO:0090257, GO:0051239, GO:0048518, GO:0008150, GO:0043502, GO:0050789
GO:0018105 [BP]peptidyl-serine phosphorylationprobableGO:0044267, GO:0006468, GO:0018209, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0009987, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0018193, GO:0008152, GO:0006793, GO:0044237
GO:0007611 [BP]learning or memoryprobableGO:0032501, GO:0044707, GO:0044708, GO:0050896, GO:0050890, GO:0007610, GO:0008150, GO:0050877, GO:0044699, GO:0003008
GO:0002062 [BP]chondrocyte differentiationprobableGO:0032502, GO:0051216, GO:0044707, GO:0048869, GO:0032501, GO:0030154, GO:0009888, GO:0061448, GO:0008150, GO:0001501, GO:0048513, GO:0044763, GO:0048731, GO:0009987, GO:0007275, GO:0044699, GO:0048856
GO:0043234 [CC]protein complexprobableGO:0005575, GO:0032991
GO:0005829 [CC]cytosolprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0003682 [MF]chromatin bindingprobableGO:0003674, GO:0005488
GO:0046627 [BP]negative regulation of insulin receptor signaling pathwayprobableGO:0009968, GO:0009966, GO:0048585, GO:0023051, GO:0048583, GO:0046626, GO:0050794, GO:0008150, GO:0023057, GO:0065007, GO:0010648, GO:1900077, GO:1900076, GO:0048519, GO:0010646, GO:0050789, GO:0048523
GO:0002159 [BP]desmosome assemblyprobableGO:0022607, GO:0034330, GO:0016043, GO:0008150, GO:0044085, GO:0007043, GO:0071840, GO:0045216, GO:0002934, GO:0044763, GO:0009987, GO:0034329, GO:0044699
GO:0031526 [CC]brush border membraneprobableGO:0016020, GO:0044464, GO:0044463, GO:0031253, GO:0005623, GO:0005575, GO:0005903, GO:0071944, GO:0005886, GO:0044425, GO:0042995, GO:0044459
GO:0005783 [CC]endoplasmic reticulumprobableGO:0005737, GO:0043231, GO:0044464, GO:0043229, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424, GO:0043227, GO:0043226
GO:0050681 [MF]androgen receptor bindingprobableGO:0035258, GO:0035257, GO:0003674, GO:0005488, GO:0005515, GO:0051427, GO:0005102
GO:0071322 [BP]cellular response to carbohydrate stimulusprobableGO:1901700, GO:1901701, GO:0051716, GO:0009743, GO:0050896, GO:0009987, GO:0008150, GO:0071310, GO:0044763, GO:0070887, GO:0042221, GO:0010033, GO:0044699
GO:0006816 [BP]calcium ion transportprobableGO:0072511, GO:0006812, GO:0006811, GO:0006810, GO:0008150, GO:0044765, GO:0030001, GO:0070838, GO:0051234, GO:0051179, GO:0044699
GO:0007190 [BP]activation of adenylate cyclase activityprobableGO:0019220, GO:0031281, GO:0019222, GO:0031328, GO:0031326, GO:0031325, GO:0031323, GO:0051339, GO:0045981, GO:0043085, GO:0009893, GO:0030819, GO:0030816, GO:0045761, GO:0045762, GO:0009891, GO:0030810, GO:0050789, GO:0065007, GO:0044093, GO:0051349, GO:0048518, GO:0065009, GO:0045935, GO:0045937, GO:0019219, GO:0050790, GO:0009889, GO:0050794, GO:0051174, GO:1900542, GO:0008150, GO:0051171, GO:0051173, GO:0030799, GO:0031279, GO:1900544, GO:1900371, GO:0030808, GO:0080090, GO:0030804, GO:0030801, GO:1900373, GO:0030802, GO:0030817, GO:0006140, GO:0030814, GO:0010562, GO:0048522
GO:0007194 [BP]negative regulation of adenylate cyclase activityprobableGO:0010563, GO:0031280, GO:0080090, GO:0019222, GO:0031327, GO:0051350, GO:0031324, GO:0031323, GO:0009892, GO:1900371, GO:0045980, GO:0043086, GO:0019220, GO:0009890, GO:0030818, GO:0045761, GO:0030814, GO:0030815, GO:0050789, GO:0065007, GO:0044092, GO:0048519, GO:0065009, GO:0045934, GO:0045936, GO:0019219, GO:0050790, GO:0009889, GO:0050794, GO:0031326, GO:1900542, GO:0008150, GO:0051171, GO:0051172, GO:0030799, GO:0031279, GO:0051174, GO:1900543, GO:0030802, GO:0030809, GO:0030808, GO:1900372, GO:0030800, GO:0030803, GO:0051339, GO:0030817, GO:0006140, GO:0048523
GO:0031397 [BP]negative regulation of protein ubiquitinationprobableGO:0032269, GO:0032268, GO:0010605, GO:0080090, GO:0019222, GO:0060255, GO:0051246, GO:0031400, GO:0031324, GO:0031323, GO:0051248, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0031399, GO:0031396, GO:0009892, GO:0050789, GO:0048523
GO:0046777 [BP]protein autophosphorylationprobableGO:0044267, GO:0006468, GO:0044260, GO:0044238, GO:0019538, GO:0016310, GO:0009987, GO:0043412, GO:0006464, GO:0043170, GO:0071704, GO:0006796, GO:0036211, GO:0008150, GO:0044237, GO:0008152, GO:0006793
GO:0043536 [BP]positive regulation of blood vessel endothelial cell migrationprobableGO:0010634, GO:0051272, GO:0030335, GO:0030334, GO:0010595, GO:0010594, GO:0010632, GO:0040017, GO:0040012, GO:0051239, GO:0043535, GO:0051270, GO:2000145, GO:0008150, GO:2000147, GO:0048518, GO:0065007, GO:0032879, GO:0050794, GO:0050789, GO:0048522
GO:0090330 [BP]regulation of platelet aggregationprobableGO:0034110, GO:0050865, GO:0030155, GO:0032101, GO:0048583, GO:1900046, GO:0050794, GO:0050789, GO:0022407, GO:0061041, GO:0065007, GO:0010543, GO:0051239, GO:0030193, GO:0008150, GO:0050818, GO:0080134
GO:0045766 [BP]positive regulation of angiogenesisprobableGO:0022603, GO:0050793, GO:0051094, GO:0045765, GO:0008150, GO:1901342, GO:2000026, GO:0051239, GO:0048518, GO:0065007, GO:0050789
GO:0001881 [BP]receptor recyclingprobableGO:0044260, GO:0009987, GO:0044237, GO:0043170, GO:0071704, GO:0065007, GO:0008152, GO:0023051, GO:0008150, GO:0043112, GO:0050789
GO:0045121 [CC]membrane raftprobableGO:0005575, GO:0044425, GO:0016020
GO:0005813 [CC]centrosomeprobableGO:0005856, GO:0005575, GO:0015630, GO:0043232, GO:0044464, GO:0005623, GO:0005815, GO:0044446, GO:0043229, GO:0043228, GO:0044430, GO:0044424, GO:0005622, GO:0043226, GO:0044422
GO:0030168 [BP]platelet activationprobableGO:0009987, GO:0007599, GO:0050878, GO:0044707, GO:0006950, GO:0032501, GO:0007596, GO:0009611, GO:0042060, GO:0065007, GO:0001775, GO:0050817, GO:0044763, GO:0008150, GO:0065008, GO:0050896, GO:0044699
GO:0032425 [BP]positive regulation of mismatch repairprobableGO:0009893, GO:0019222, GO:0031325, GO:0048584, GO:0048583, GO:0045935, GO:0050789, GO:0080090, GO:0010604, GO:0019219, GO:0065007, GO:0048518, GO:0032423, GO:0051054, GO:0006282, GO:0051052, GO:0060255, GO:0031323, GO:0050794, GO:0008150, GO:0051171, GO:0051173, GO:2001020, GO:2001022, GO:0080134, GO:0080135, GO:0045739, GO:0048522
GO:0035403 [MF]histone kinase activity (H3-T6 specific)probableGO:0035184, GO:0016773, GO:0016772, GO:0003824, GO:0016301, GO:0035173, GO:0004674, GO:0016740, GO:0003674, GO:0004672
GO:0035408 [BP]histone H3-T6 phosphorylationprobableGO:0018107, GO:0016310, GO:0018193, GO:0044699, GO:0016043, GO:0044267, GO:0044260, GO:0006325, GO:0071840, GO:0018210, GO:0071704, GO:0016570, GO:0016572, GO:0006468, GO:0009987, GO:0006464, GO:0043412, GO:0035405, GO:0008150, GO:0008152, GO:0006996, GO:0044238, GO:0051276, GO:0019538, GO:0044237, GO:0043170, GO:0006796, GO:0036211, GO:0006793, GO:0044763, GO:0016568, GO:0016569
GO:0042177 [BP]negative regulation of protein catabolic processprobableGO:0051248, GO:0009895, GO:0010605, GO:0080090, GO:0019222, GO:0060255, GO:0051246, GO:0009894, GO:0008150, GO:0042176, GO:0065007, GO:0048519, GO:0009892, GO:0050789
GO:0048471 [CC]perinuclear region of cytoplasmprobableGO:0005737, GO:0044464, GO:0005623, GO:0005622, GO:0005575, GO:0044444, GO:0044424
GO:0070555 [BP]response to interleukin-1probableGO:0042221, GO:0050896, GO:0008150, GO:0034097, GO:0010033
GO:0045471 [BP]response to ethanolprobableGO:1901700, GO:0050896, GO:0008150, GO:0042221, GO:0097305, GO:0010033
GO:0005246 [MF]calcium channel regulator activityprobableGO:0016247, GO:0003674
GO:0005080 [MF]protein kinase C bindingprobableGO:0019899, GO:0019901, GO:0019900, GO:0003674, GO:0005488, GO:0005515
GO:0042393 [MF]histone bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0006874 [BP]cellular calcium ion homeostasisprobableGO:0019725, GO:0072507, GO:0072503, GO:0006875, GO:0050801, GO:0009987, GO:0006873, GO:0048878, GO:0042592, GO:0065007, GO:0044763, GO:0055074, GO:0030003, GO:0055065, GO:0055080, GO:0008150, GO:0055082, GO:0065008, GO:0044699
GO:0034351 [BP]negative regulation of glial cell apoptotic processprobableGO:0043069, GO:0034350, GO:0050794, GO:0008150, GO:0043067, GO:0043066, GO:0065007, GO:0060548, GO:0048519, GO:0010941, GO:0042981, GO:0050789, GO:0048523
GO:0048265 [BP]response to painprobableGO:0032501, GO:0044707, GO:0050896, GO:0006950, GO:0008150, GO:0033555, GO:0044699
GO:0051495 [BP]positive regulation of cytoskeleton organizationprobableGO:0051130, GO:0033043, GO:0010638, GO:0051493, GO:0051128, GO:0065007, GO:0048518, GO:0008150, GO:0050794, GO:0050789, GO:0048522
GO:0030593 [BP]neutrophil chemotaxisprobableGO:0006928, GO:0050900, GO:0051674, GO:0070887, GO:0060326, GO:0044699, GO:0051716, GO:0042330, GO:0071621, GO:0030595, GO:0006935, GO:0009987, GO:0044763, GO:0042221, GO:0051179, GO:0040011, GO:0016477, GO:0009605, GO:0048870, GO:0050896, GO:0002376, GO:0008150
GO:0050930 [BP]induction of positive chemotaxisprobableGO:0040012, GO:0032103, GO:0040017, GO:0032101, GO:0048584, GO:0048583, GO:0050795, GO:0050789, GO:0008150, GO:0050926, GO:0050927, GO:0050920, GO:0050921, GO:0048518, GO:0065007, GO:0048520
GO:0000302 [BP]response to reactive oxygen speciesprobableGO:1901700, GO:0050896, GO:0006950, GO:0008150, GO:0042221, GO:0006979
GO:0050730 [BP]regulation of peptidyl-tyrosine phosphorylationprobableGO:0042325, GO:0032268, GO:0019220, GO:0080090, GO:0019222, GO:0060255, GO:0031323, GO:0051246, GO:0050794, GO:0051174, GO:0065007, GO:0031399, GO:0008150, GO:0001932, GO:0050789
GO:0005654 [CC]nucleoplasmprobableGO:0005575, GO:0043231, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0031974, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0044428, GO:0005623, GO:0044424, GO:0043227, GO:0043226, GO:0044422
GO:0032956 [BP]regulation of actin cytoskeleton organizationprobableGO:0033043, GO:0032970, GO:0051493, GO:0051128, GO:0065007, GO:0008150, GO:0050794, GO:0050789
GO:0016071 [BP]mRNA metabolic processprobableGO:0016070, GO:0006139, GO:0044260, GO:0044238, GO:0009987, GO:0006725, GO:0044237, GO:0043170, GO:0090304, GO:0071704, GO:0034641, GO:0006807, GO:0008150, GO:0008152, GO:1901360, GO:0046483
GO:0050714 [BP]positive regulation of protein secretionprobableGO:0032880, GO:0070201, GO:0032879, GO:0050708, GO:0060341, GO:0051046, GO:0051047, GO:0051049, GO:0051050, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0051222, GO:0051223, GO:0050789, GO:0048522
GO:0042488 [BP]positive regulation of odontogenesis of dentin-containing toothprobableGO:0051094, GO:0050793, GO:0042481, GO:0042482, GO:0022603, GO:0042487, GO:0008150, GO:2000026, GO:2000027, GO:0051239, GO:0048518, GO:0065007, GO:0050789
GO:0008285 [BP]negative regulation of cell proliferationprobableGO:0042127, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0097193 [BP]intrinsic apoptotic signaling pathwayprobableGO:0010259, GO:0044700, GO:0051716, GO:0009987, GO:0050896, GO:0006915, GO:0097190, GO:0050794, GO:0008150, GO:0012501, GO:0065007, GO:0044763, GO:0007165, GO:0023052, GO:0007154, GO:0035556, GO:0007569, GO:0050789, GO:0044699
GO:0032355 [BP]response to estradiol stimulusprobableGO:1901700, GO:0009719, GO:0033993, GO:0050896, GO:0008150, GO:0014070, GO:0009725, GO:0043627, GO:0042221, GO:0097305, GO:0010033, GO:0048545
GO:0043524 [BP]negative regulation of neuron apoptotic processprobableGO:0010941, GO:0060548, GO:0043066, GO:0050794, GO:0008150, GO:0043067, GO:0043523, GO:0065007, GO:0048523, GO:0048519, GO:1901214, GO:1901215, GO:0042981, GO:0050789, GO:0043069
GO:0050729 [BP]positive regulation of inflammatory responseprobableGO:0032103, GO:0032101, GO:0080134, GO:0048584, GO:0048583, GO:0050727, GO:0031349, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0031347
GO:0045785 [BP]positive regulation of cell adhesionprobableGO:0030155, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0006937 [BP]regulation of muscle contractionprobableGO:0044057, GO:0008150, GO:0090257, GO:0051239, GO:0065007, GO:0050789
GO:0031666 [BP]positive regulation of lipopolysaccharide-mediated signaling pathwayprobableGO:0009966, GO:0009967, GO:0048584, GO:0002831, GO:0031664, GO:0050794, GO:0023056, GO:0043900, GO:0065007, GO:0002833, GO:0048583, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0050789, GO:0048522
GO:0045651 [BP]positive regulation of macrophage differentiationprobableGO:0002761, GO:0045597, GO:0002763, GO:0045649, GO:0051094, GO:0050793, GO:0065007, GO:0045595, GO:0050794, GO:1902107, GO:0050789, GO:1902105, GO:0045639, GO:0002682, GO:0008150, GO:0051239, GO:0048518, GO:2000026, GO:0045637, GO:0048522
GO:0001934 [BP]positive regulation of protein phosphorylationprobableGO:0019220, GO:0009893, GO:0019222, GO:0031325, GO:0031323, GO:0050789, GO:0080090, GO:0010604, GO:0010562, GO:0051246, GO:0051247, GO:0032270, GO:0031399, GO:0048518, GO:0065007, GO:0045937, GO:0060255, GO:0050794, GO:0051174, GO:0008150, GO:0042325, GO:0042327, GO:0032268, GO:0031401, GO:0001932, GO:0048522
GO:0035162 [BP]embryonic hemopoiesisprobableGO:0032502, GO:0002376, GO:0032501, GO:0044707, GO:0048568, GO:0048856, GO:0044767, GO:0009790, GO:0048513, GO:0008150, GO:0048731, GO:0030097, GO:0048534, GO:0007275, GO:0044699, GO:0002520
GO:0046325 [BP]negative regulation of glucose importprobableGO:0051051, GO:0051049, GO:0008150, GO:0010827, GO:0065007, GO:0046324, GO:0048519, GO:0032879, GO:0010829, GO:0050789
GO:0016363 [CC]nuclear matrixprobableGO:0034399, GO:0005575, GO:0043231, GO:0031981, GO:0043233, GO:0005634, GO:0044464, GO:0005623, GO:0005622, GO:0044446, GO:0070013, GO:0043229, GO:0044428, GO:0031974, GO:0044424, GO:0043227, GO:0043226, GO:0044422
GO:0045822 [BP]negative regulation of heart contractionprobableGO:0008016, GO:0044057, GO:0051241, GO:0008150, GO:0065007, GO:0051239, GO:0048519, GO:0050789
GO:0050796 [BP]regulation of insulin secretionprobableGO:0090087, GO:0032879, GO:0060341, GO:0051046, GO:0002791, GO:0050794, GO:0008150, GO:0090276, GO:0046883, GO:0051049, GO:0023051, GO:0065007, GO:0010646, GO:0050789
GO:0060074 [BP]synapse maturationprobableGO:0032502, GO:0050808, GO:0044707, GO:0007399, GO:0008150, GO:0009987, GO:0016043, GO:0044767, GO:0032501, GO:0044763, GO:0071840, GO:0048731, GO:0010259, GO:0007275, GO:0044699, GO:0048856
GO:0051965 [BP]positive regulation of synapse assemblyprobableGO:0019226, GO:0035637, GO:0050803, GO:0050807, GO:0051128, GO:0023052, GO:0050789, GO:0044699, GO:0044087, GO:0065007, GO:0048518, GO:0065008, GO:0051130, GO:0032501, GO:0050793, GO:0050877, GO:0009987, GO:0050794, GO:0008150, GO:0051239, GO:0007268, GO:0007267, GO:0007154, GO:0003008, GO:0044700, GO:0044707, GO:0051094, GO:0051963, GO:0051962, GO:0051960, GO:2000026, GO:0044763, GO:0044089, GO:0048522
GO:0002026 [BP]regulation of the force of heart contractionprobableGO:0044057, GO:0008016, GO:0008150, GO:0051239, GO:0065007, GO:0065008, GO:0050789
GO:0021955 [BP]central nervous system neuron axonogenesisprobableGO:0032502, GO:0044707, GO:0030030, GO:0030154, GO:0048468, GO:0031175, GO:0009653, GO:0007275, GO:0044699, GO:0007417, GO:0000904, GO:0000902, GO:0048869, GO:0016043, GO:0032989, GO:0008150, GO:0071840, GO:0021954, GO:0021953, GO:0048666, GO:0048667, GO:0032501, GO:0030182, GO:0009987, GO:0044767, GO:0044763, GO:0007409, GO:0022008, GO:0032990, GO:0048699, GO:0048858, GO:0007399, GO:0048856, GO:0048812, GO:0048731
GO:2000707 [BP]positive regulation of dense core granule biogenesisprobableGO:0050794, GO:0044087, GO:0065007, GO:0048518, GO:0008150, GO:0044089, GO:0050789, GO:2000705, GO:0048522
GO:0043278 [BP]response to morphineprobableGO:0009719, GO:0050896, GO:0060359, GO:1901698, GO:0010033, GO:0008150, GO:0042221, GO:0043279, GO:0014072, GO:0010243, GO:0014070
GO:0070374 [BP]positive regulation of ERK1 and ERK2 cascadeprobableGO:0023056, GO:0048584, GO:0010646, GO:0009966, GO:0009967, GO:0010740, GO:0048583, GO:0050794, GO:0043410, GO:0050789, GO:0065007, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0048522, GO:0010627, GO:0070372, GO:0043408
GO:0035206 [BP]regulation of hemocyte proliferationprobableGO:0042127, GO:0050793, GO:0050794, GO:0008150, GO:0002682, GO:0051239, GO:0065007, GO:0050789
GO:0050861 [BP]positive regulation of B cell receptor signaling pathwayprobableGO:0050854, GO:0050855, GO:0050857, GO:0009966, GO:0009967, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0002684, GO:0002682, GO:0008150, GO:0023051, GO:0048518, GO:0065007, GO:0010647, GO:0010646, GO:0050789, GO:0048522
GO:0001525 [BP]angiogenesisprobableGO:0032502, GO:0032501, GO:0044707, GO:0001568, GO:0048856, GO:0001944, GO:0044767, GO:0072359, GO:0072358, GO:0048514, GO:0048646, GO:0048731, GO:0008150, GO:0009653, GO:0007275, GO:0044699
GO:0045931 [BP]positive regulation of mitotic cell cycleprobableGO:0007346, GO:0045787, GO:0051726, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0009749 [BP]response to glucose stimulusprobableGO:0009746, GO:1901700, GO:0009743, GO:0034284, GO:0050896, GO:0008150, GO:0042221, GO:0010033
GO:0097110 [MF]scaffold protein bindingprobableGO:0003674, GO:0005488, GO:0005515
GO:0043123 [BP]positive regulation of I-kappaB kinase/NF-kappaB cascadeprobableGO:0023051, GO:0009966, GO:0010740, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0065007, GO:0009967, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0010627, GO:0050789, GO:0043122, GO:0048522
GO:0001938 [BP]positive regulation of endothelial cell proliferationprobableGO:0008284, GO:0042127, GO:0050678, GO:0050679, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0001936, GO:0050789, GO:0048522
GO:0007173 [BP]epidermal growth factor receptor signaling pathwayprobableGO:0044700, GO:0051716, GO:0008150, GO:0050896, GO:0009987, GO:0050794, GO:0023052, GO:0007154, GO:0065007, GO:0044763, GO:0007165, GO:0007166, GO:0007167, GO:0007169, GO:0050789, GO:0044699, GO:0038127
GO:0043434 [BP]response to peptide hormone stimulusprobableGO:1901700, GO:0009719, GO:0050896, GO:0009725, GO:0010243, GO:1901698, GO:0008150, GO:1901652, GO:0042221, GO:0010033
GO:0031594 [CC]neuromuscular junctionprobableGO:0005575, GO:0045202
GO:0005524 [MF]ATP bindingprobableGO:0043168, GO:0003674, GO:0005488, GO:0030554, GO:0035639, GO:0097159, GO:1901363, GO:0043167, GO:0036094, GO:0032553, GO:0032559, GO:0001883, GO:0032549, GO:0032555, GO:0017076, GO:0000166, GO:0032550, GO:1901265, GO:0001882
GO:0033554 [BP]cellular response to stressprobableGO:0051716, GO:0050896, GO:0009987, GO:0006950, GO:0044763, GO:0008150, GO:0044699
GO:0051412 [BP]response to corticosterone stimulusprobableGO:1901700, GO:0009719, GO:0051385, GO:0051384, GO:0031960, GO:0050896, GO:0009725, GO:1901654, GO:0008150, GO:0014070, GO:0033993, GO:0042221, GO:0097305, GO:0010033, GO:0048545
GO:0042493 [BP]response to drugprobableGO:0042221, GO:0050896, GO:0008150
GO:0030374 [MF]ligand-dependent nuclear receptor transcription coactivator activityprobableGO:0003674, GO:0003713, GO:0003712, GO:0000989, GO:0000988
GO:0001772 [CC]immunological synapseprobableGO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886, GO:0044425, GO:0044459
GO:0048011 [BP]neurotrophin TRK receptor signaling pathwayprobableGO:0007166, GO:0007167, GO:0023052, GO:0007165, GO:0070887, GO:0007154, GO:0007169, GO:0050789, GO:0044699, GO:0051716, GO:0070848, GO:0071310, GO:0065007, GO:0038179, GO:0009987, GO:0050794, GO:0008150, GO:0042221, GO:0010033, GO:0044700, GO:0071363, GO:0050896, GO:0044763
GO:0006351 [BP]transcription, DNA-dependentprobableGO:0032774, GO:0090304, GO:0044249, GO:0034641, GO:0006807, GO:0034645, GO:1901362, GO:1901360, GO:1901576, GO:0044260, GO:0071704, GO:0010467, GO:0018130, GO:0006139, GO:0009987, GO:0006725, GO:0009058, GO:0009059, GO:0008150, GO:0008152, GO:0034654, GO:0046483, GO:0016070, GO:0044238, GO:0044271, GO:0044237, GO:0043170, GO:0019438
GO:0046677 [BP]response to antibioticprobableGO:0008150, GO:0042221, GO:0050896, GO:0009636
GO:0008543 [BP]fibroblast growth factor receptor signaling pathwayprobableGO:0007166, GO:0007167, GO:0070848, GO:0023052, GO:0007165, GO:0070887, GO:0042221, GO:0007169, GO:0050789, GO:0044699, GO:0009719, GO:0051716, GO:0044344, GO:0071310, GO:0065007, GO:0071495, GO:0009987, GO:0050794, GO:0044763, GO:0007154, GO:0010033, GO:0044700, GO:0071363, GO:0050896, GO:0071774, GO:0008150
GO:0006509 [BP]membrane protein ectodomain proteolysisprobableGO:0044238, GO:0019538, GO:0033619, GO:0043170, GO:0071704, GO:0008150, GO:0008152, GO:0006508
GO:0008047 [MF]enzyme activator activityprobableGO:0030234, GO:0003674
GO:0042119 [BP]neutrophil activationprobableGO:0009987, GO:0002274, GO:0002376, GO:0045321, GO:0001775, GO:0036230, GO:0008150, GO:0044763, GO:0044699
GO:0042113 [BP]B cell activationprobableGO:0009987, GO:0002376, GO:0045321, GO:0001775, GO:0046649, GO:0044763, GO:0008150, GO:0044699
GO:0014059 [BP]regulation of dopamine secretionprobableGO:0032879, GO:0060341, GO:0051046, GO:0051049, GO:0050794, GO:0008150, GO:0050433, GO:0023051, GO:0051952, GO:0065007, GO:0010646, GO:0050789, GO:0043269
GO:0050853 [BP]B cell receptor signaling pathwayprobableGO:0048584, GO:0048583, GO:0023052, GO:0007165, GO:0007166, GO:0050789, GO:0044699, GO:0051716, GO:0002764, GO:0002768, GO:0002684, GO:0002682, GO:0048518, GO:0065007, GO:0050851, GO:0002757, GO:0009987, GO:0050794, GO:0050776, GO:0008150, GO:0007154, GO:0044700, GO:0002429, GO:0050896, GO:0050778, GO:0002376, GO:0002253, GO:0044763
GO:0006917 [BP]induction of apoptosisprobableGO:0050789, GO:0043067, GO:0050794, GO:0043065, GO:0048518, GO:0012502, GO:0065007, GO:0010942, GO:0008150, GO:0010941, GO:0042981, GO:0043068, GO:0048522
GO:0031966 [CC]mitochondrial membraneprobableGO:0005737, GO:0005575, GO:0031090, GO:0043229, GO:0016020, GO:0044464, GO:0044444, GO:0031967, GO:0031975, GO:0044446, GO:0005740, GO:0005739, GO:0044429, GO:0044424, GO:0005623, GO:0005622, GO:0043227, GO:0043226, GO:0044422, GO:0043231
GO:0051489 [BP]regulation of filopodium assemblyprobableGO:0051128, GO:0044087, GO:0060491, GO:0065007, GO:0008150, GO:0050794, GO:0031344, GO:0050789
GO:0008270 [MF]zinc ion bindingprobableGO:0043169, GO:0046914, GO:0043167, GO:0003674, GO:0005488, GO:0046872
GO:0017148 [BP]negative regulation of translationprobableGO:0009892, GO:0080090, GO:0009890, GO:0031327, GO:2000112, GO:0031324, GO:0031323, GO:0050789, GO:0051248, GO:0010605, GO:0019222, GO:0010608, GO:0051246, GO:2000113, GO:0065007, GO:0031326, GO:0048519, GO:0010468, GO:0060255, GO:0009889, GO:0050794, GO:0008150, GO:0032269, GO:0032268, GO:0010556, GO:0006417, GO:0010558, GO:0048523
GO:0009612 [BP]response to mechanical stimulusprobableGO:0009628, GO:0050896, GO:0008150, GO:0009605
GO:0007202 [BP]activation of phospholipase C activityprobableGO:0051336, GO:0060193, GO:0060191, GO:0019222, GO:0051345, GO:0050790, GO:0050789, GO:0010518, GO:1900274, GO:0065007, GO:0043085, GO:0044093, GO:0008150, GO:0010863, GO:0065009, GO:0010517
GO:0007635 [BP]chemosensory behaviorprobableGO:0042221, GO:0050896, GO:0008150, GO:0007610, GO:0044708
GO:0006357 [BP]regulation of transcription from RNA polymerase II promoterprobableGO:0009889, GO:0019219, GO:0080090, GO:0019222, GO:0060255, GO:0031326, GO:0031323, GO:0051252, GO:2000112, GO:0050794, GO:0050789, GO:0006355, GO:0010556, GO:0065007, GO:0051171, GO:2001141, GO:0008150, GO:0010468
GO:0004699 [MF]calcium-independent protein kinase C activityprobableGO:0003824, GO:0016773, GO:0016772, GO:0016301, GO:0004674, GO:0016740, GO:0003674, GO:0004672, GO:0004697
GO:0016028 [CC]rhabdomereprobableGO:0005575, GO:0042995, GO:0044464, GO:0005623
GO:0042383 [CC]sarcolemmaprobableGO:0016020, GO:0044464, GO:0005623, GO:0005575, GO:0071944, GO:0005886
GO:0030949 [BP]positive regulation of vascular endothelial growth factor receptor signaling pathwayprobableGO:0090287, GO:0030947, GO:0009966, GO:0009967, GO:0048584, GO:0048583, GO:0050794, GO:0023056, GO:0065007, GO:0023051, GO:0048518, GO:0008150, GO:0010647, GO:0010646, GO:0050789, GO:0048522
GO:0033280 [BP]response to vitamin DprobableGO:1901700, GO:0009991, GO:0009605, GO:0033993, GO:0007584, GO:0031667, GO:0050896, GO:0033273, GO:0008150, GO:0042221, GO:0097305, GO:0010033, GO:0014070
GO:0001666 [BP]response to hypoxiaprobableGO:0009628, GO:0036293, GO:0050896, GO:0006950, GO:0008150, GO:0070482
GO:0006112 [BP]energy reserve metabolic processprobableGO:0044710, GO:0015980, GO:0009987, GO:0044237, GO:0008150, GO:0008152, GO:0006091, GO:0055114
GO:0018894 [BP]dibenzo-p-dioxin metabolic processprobableGO:0044710, GO:0009987, GO:0006725, GO:0044237, GO:0071704, GO:0008150, GO:0044281, GO:0008152, GO:1901360, GO:0046483
GO:0051092 [BP]positive regulation of NF-kappaB transcription factor activityprobableGO:0080090, GO:0019222, GO:0031326, GO:0031323, GO:0050789, GO:2000112, GO:0060255, GO:0065007, GO:0044093, GO:0065009, GO:0010468, GO:0019219, GO:0009889, GO:0050794, GO:0008150, GO:0051171, GO:2001141, GO:0051091, GO:0051090, GO:0051252, GO:0006355, GO:0010556
GO:0048259 [BP]regulation of receptor-mediated endocytosisprobableGO:0032879, GO:0051049, GO:0051128, GO:0060627, GO:0065007, GO:0008150, GO:0050794, GO:0030100, GO:0050789
GO:0042953 [BP]lipoprotein transportprobableGO:0033036, GO:0008104, GO:0006810, GO:0045184, GO:0044765, GO:0008150, GO:0071702, GO:0015031, GO:0051234, GO:0051179, GO:0044699
GO:0060384 [BP]innervationprobableGO:0032502, GO:0032501, GO:0044707, GO:0007399, GO:0048856, GO:0044767, GO:0008150, GO:0048731, GO:0021675, GO:0007275, GO:0044699
GO:0000188 [BP]inactivation of MAPK activityprobableGO:0033673, GO:0043549, GO:0019220, GO:0080090, GO:0019222, GO:0044092, GO:0048585, GO:0031324, GO:0048583, GO:0043407, GO:0023057, GO:0043405, GO:0010648, GO:0023051, GO:0009892, GO:0071901, GO:0071900, GO:0010627, GO:0043086, GO:0043409, GO:0043408, GO:0051248, GO:0010646, GO:0010605, GO:0009968, GO:0009966, GO:0051348, GO:0051246, GO:0050789, GO:0065007, GO:0031399, GO:0048519, GO:0065009, GO:0010741, GO:0006469, GO:0045936, GO:0060255, GO:0031323, GO:0045859, GO:0050794, GO:0051174, GO:0032268, GO:0008150, GO:0042325, GO:0032269, GO:0042326, GO:0050790, GO:0010563, GO:0031400, GO:0051338, GO:0001933, GO:0001932, GO:0048523
GO:0040008 [BP]regulation of growthprobableGO:0008150, GO:0065007, GO:0050789
GO:0045921 [BP]positive regulation of exocytosisprobableGO:0032879, GO:0060341, GO:0051046, GO:0051047, GO:0051049, GO:0051050, GO:0060627, GO:0065007, GO:0048522, GO:0048518, GO:0008150, GO:0050794, GO:0050789, GO:0017157
GO:0005911 [CC]cell-cell junctionprobableGO:0005575, GO:0030054
GO:0048661 [BP]positive regulation of smooth muscle cell proliferationprobableGO:0008284, GO:0042127, GO:0048660, GO:0050794, GO:0065007, GO:0048518, GO:0008150, GO:0050789, GO:0048522
GO:0007155 [BP]cell adhesionprobableGO:0008150, GO:0009987, GO:0022610, GO:0044763, GO:0044699

Prediction of Enzyme Commission Number ?

No confident prediction of EC number!


Spatial Structural Prediction

Structural Models Based on Templates

Template: 3PFQ, chain A
Confidence level:very confident
Coverage over the Query: 42-63
View the alignment between query and template
View the model in PyMOL